Frontline Management of Atopic Dermatitis in Adults - Episode 18

Future Directions in the Management Atopic Dermatitis in Adult Patients

Published on: April 14, 2025

Brad P. Glick, DO, MPH, Zed Zha, MD, FAAFP, Charles Vega, MD, FAAFP, Mona Shahriari, MD, FAAD, Michael R. Nazareth, MD, PhD, FAAD

Panelists discuss how the future of atopic dermatitis treatments is evolving with novel biologics, Janus kinase inhibitors, and precision medicine targeting immune pathways. Advances in gene therapy, microbiome modulation, and personalized treatments offer promising long-term management options.

EP. 1: Frontline Management of Atopic Dermatitis in Adults

EP. 2: Considerations for Diagnosis of Atopic Dermatitis in Adults

EP. 3: A Primary Care Perspective on Diagnosing Atopic Dermatitis

EP. 4: Strategies for Determining Severity of Atopic Dermatitis

EP. 5: Collaboration Between Primary Care and Dermatology in Atopic Dermatitis Care

EP. 6: The Utility of Newer Topical Therapies for Atopic Dermatitis

EP. 7: The Impact of Biologics on a Changing Atopic Dermatitis Treatment Landscape

EP. 8: A Primary Care Perspective on Newer-Generation Systemic Therapies

EP. 9: Safety of Systemic Agents in Atopic Dermatitis Management

EP. 10: LIBERTY AD Open-Label Extension Analysis: Takeaways and Considerations

EP. 11: ECZTEND 2-Year Interim Findings: Takeaways and Considerations

EP. 12: Rapid Efficacy and Safety Considerations With the Use of JAK Inhibitors in Atopic Dermatitis Care

EP. 13: Safety Protocols With JAK Inhibitors

EP. 14: JADE COMPARE: Considerations for Comparisons Among Systemic Agents in Atopic Dermatitis

EP. 15: Evaluation of Long-Term Data With JAK Inhibitors

EP. 16: Clinical Considerations for Choosing a Systemic Agent for Patients With Atopic Dermatitis

EP. 17: Multispecialty Perspectives on Shared Decision-Making in Atopic Dermatitis Care

EP. 18: Future Directions in the Management Atopic Dermatitis in Adult Patients

Video content above in prompted by the following:

Please provide your final thoughts on the future of atopic dermatitis treatments.

Advertisement

Advertisement